secwatch.observer — SEC 8-K summary
======================================

Issuer:     Advanced Biomed Inc. (ADVB)
CIK:        0001941029
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001213900-25-052234
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Advanced Biomed secures up to $25M equity purchase agreement with Helena Global
-------------------------------------------------------------------------------

- Company enters purchase agreement with HELENA GLOBAL for up to $25M of common stock.
- Company may sell shares at its discretion; purchase price equals lowest intraday price during a 3-day pricing period.
- Maximum advance capped at the lesser of 25% of 5-day average daily value traded or $2M per draw.
- Investor ownership limitation set at 4.99% of outstanding common stock.
- Agreement dated June 6, 2025; shares to be sold in reliance on Section 4(a)(2) exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1941029/000121390025052234/0001213900-25-052234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1941029/000121390025052234/ea0243953-8k_advanced.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-052234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer